Biomarkers In Prediction of Acute Mesenteric Ischaemia (BIPAMI): a prospective multicentre international study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background: Available evidence on biomarkers of acute mesenteric ischaemia (AMI) is limited due to unclear reporting of AMI mechanisms, localization and severity and random time points for biomarker sampling. The primary aim of this study was to identify a combination of biomarkers allowing accurate identification of transmural AMI, the primary determinant of outcome. Methods: In this prospective multicentre study, consecutive adult patients admitted with suspected AMI during one-year recruitment period were included before any AMI-directed intervention. Serial blood samples were collected during up to 72 hours from admission. Intestinal fatty acid-binding protein (iFABP), alpha-glutathione S-transferase (alpha- GST), ischaemia-modified albumin (IMA), D-lactate, signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1), lipopolysaccharide-binding protein (LBP), interleukin 6 (IL-6), procalcitonin, D-dimers, acid-base status, lactate, C-reactive protein (CRP), white blood cell count, creatinine and troponin were analysed. Biomarker accuracy was assessed by ROC analysis. Optimal biomarker combination was determined by exhaustive logistic regression modelling and cut-offs by multi-objective (Pareto) optimization. Internal validation was performed using bootstrap resampling. Results: Thirteen sites from six European countries included in total 256 patients, among them 86 without AMI, 158 with AMI and 12 with strangulating bowel obstruction identified only after study inclusion. No individual biomarker or biomarker combination accurately distinguished AMI from non-AMI. However, among patients with classical AMI (arterial occlusive, venous and non-occlusive mesenteric ischaemia [NOMI]), a combination of five biomarkers (IL-6, alpha-GST, CRP, Scube-1 and blood lactate) discriminated transmural (n=86) from non-transmural AMI (n=39) with AUC of 0.872 (0.802-0.942), positive likelihood ratio of 5.52 and negative likelihood ratio of 0.18. The presence of at least two of the following biomarkers above threshold values correctly classified 106/125 (85%) patients: IL-6 >130 ng/L, alpha-GST >2200 µg/L, CRP >180 mg/L, SCUBE-1 >22 µg/L, blood lactate >5.5 mmol/L. Conclusions: Although biomarkers could not reliably distinguish AMI from non-AMI in patients presenting with suspected disease, a five-biomarker panel identified transmural bowel injury with acceptable accuracy. These findings suggest that circulating biomarkers primarily reflect the extent of intestinal injury and necrosis rather than the presence of AMI itself, making them potentially valuable for identification of AMI patients with irreversible bowel damage requiring urgent intervention. Study registration: NCT06212921 (Registration Date 19–01-2024).
Source: Research Square
Authors: Annika Reintam Blaser, Merli Koitmäe, Stefan Acosta, Anneli Aus, Alan Biloslavo, Giada Bracalente, Dumitru Casian, Juan Antonio Celi de la Torre, Valerio Cozza, Antonella Cotoia, Nicola Curlo, Maani Hakimi, Meis Jawad, Kalle Kisand, Karl Kustav Kuning, Ingrida Lisauskiene, Alessandra Marano, Manuela Mastronardi, Vladislav Mihnovitš, Marko Murruste, Mildred Mustkivi, Salvatore Notaro, Henrikas Paužas, Eugenio Piscitelli, Simone Piva, Elisabetta Roberti, Michèle Schöb, Mindaugas Serpytis, Hiie Soeorg, Yasmin Soltanzadeh-Naderi, Elina Sor, Joel Starkopf, Algimantas Tamelis, Diego Visconti, Anna-Liisa Voomets, Kadri Tamme, BIPAMI study group
Institutions: University of Tartu, Lund University, Tartu University Hospital, Ospedale di Cattinara, Università Cattolica del Sacro Cuore, Nicolae Testemițanu State University of Medicine and Pharmacy, Luzerner Kantonsspital, Agostino Gemelli University Polyclinic, University of Foggia, Ospedali Riuniti di Foggia, North Estonia Medical Centre, Vilnius University, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Ospedale Monaldi, Lithuanian University of Health Sciences, University of Brescia, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Eesti Teadusagentuur
OpenAlex ID: W7236175006
